Group One Trading’s Microbot Medical MBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$76.5K Sell
63,764
-42,665
-40% -$68.8K ﹤0.01% 4935
2026
Q2
$208K Buy
106,429
+59,866
+129% +$122K ﹤0.01% 4254
2026
Q1
$112K Buy
+46,563
New +$104K ﹤0.01% 4624
2025
Q4
– Sell
-18,625
Closed -$44.1K – 8747
2025
Q3
$56.8K Buy
+18,625
New +$58.1K ﹤0.01% 5847
2024
Q3
– Sell
-4,560
Closed -$4.65K – 7047
2024
Q2
$4.65K Sell
4,560
-1,077
-19% -$1.11K ﹤0.01% 5986
2024
Q1
$6.93K Buy
5,637
+500
+10% +$634 ﹤0.01% 6049
2023
Q4
$8.42K Buy
5,137
+4,338
+543% +$5.78K ﹤0.01% 6287
2023
Q3
$1.11K Sell
799
-1,101
-58% -$2.39K ﹤0.01% 7197
2023
Q2
$5.17K Buy
+1,900
New +$3.81K ﹤0.01% 6700

Other funds holding MBOT

Group One Trading's MBOT Position: Q3 2026 in Review

Group One Trading reduced its Microbot Medical (MBOT) stake by 40% in Q3 2026, selling an estimated $68.8K and leaving 63,764 shares worth $76.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4935.

Group One Trading first reported a position in MBOT in Q2 2023 and has held it in 9 quarters since. The position peaked at $208K in Q2 2026. 39 funds tracked by Wall St. Rank hold MBOT as of Q3 2026.

  • Group One Trading held 63,764 shares of Microbot Medical worth $76.5K as of Q3 2026.
  • Group One Trading sold 42,665 Microbot Medical shares in Q3 2026, an estimated $68.8K.
  • Microbot Medical made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #4935 holding.
  • Group One Trading first reported a position in Microbot Medical in Q2 2023 and has held it in 9 quarters since.
  • Group One Trading's Microbot Medical position peaked at $208K in Q2 2026.
  • 39 funds tracked by Wall St. Rank held Microbot Medical as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.